Skip to main content

Table 1 Clinical characteristics of the study groups

From: Metabolomic diferences between COVID-19 and H1N1 influenza induced ARDS

Clinical characteristic

IAP (n = 20)

COVID-19 (n = 18)

p value*

Age

49 (38–71)

60 (54–72)

0.035

Sex (female)

8 (40)

5 (28)

0.506

SAPS II

31 (23–39)

31 (27–34)

0.784

SOFA score

5 (4–7)

4 (3–8)

0.621

PaO2/FiO2

179 (73–230)

118 (99–219)

0.759

Nonsurvivors

3 (15)

5 (28)

0.438

AKI

8 (45)

9 (45)

1.000

Patients receiving noradenaline

14 (70)

4 (22)

0.004

  1. Values are medians (percentile 25th–percentile 75th), or n and percentage
  2. SAPS II, Simplified Acute Physiology Score II; SOFA score, Sequential Organ Failure Assessment score; AKI, acute kidney injury
  3. *Chi-square test (or Fisher's exact for cells counts < 5) for qualitative variables or Mann Whitney U test for quantitative variables
Back to article page

Critical Care

ISSN: 1364-8535